Filing Details

Accession Number:
0001566028-13-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-10 16:52:22
Reporting Period:
2013-10-08
Filing Date:
2013-10-10
Accepted Time:
2013-10-10 16:52:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887497 Hi Tech Pharmacal Co Inc HITK Pharmaceutical Preparations (2834) 112638720
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1054694 S David Seltzer C/O Hi-Tech Pharmacal Co., Inc.
369 Bayview Avenue
Amityville NY 11701
Ceo, President, Sec'y, Treas. Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-10-08 23,000 $43.09 1,290,703 No 4 S Direct
Common Stock Disposition 2013-10-09 26,091 $43.09 1,264,612 No 4 F Direct
Common Stock Acquisiton 2013-10-09 75,000 $14.99 1,339,612 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 F Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-10-09 75,000 $0.00 75,000 $14.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2004-12-04 2013-12-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 167,445 Indirect By Spouse and Issue
Common Stock 57,482 Indirect As Trustee of Trust for the Benefit of his Child
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.06 to $43.12, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan
  3. The option became exercisable in four (4) equal installments beginning on the first anniversary of the grant date.
  4. Other than the option reflected on this form, Mr. Seltzer is also the holder of additional options to acquire an aggregate of 475,000 additional shares of Hi-Tech Common Stock, which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.